Skip to main content
Premium Trial:

Request an Annual Quote

Survey of Australian Physicians' Engagement in Genomic Medicine

In a survey, 42 percent of Australian physicians said that having a better understanding of genomics might change their clinical practice, but the same portion also said they were not sure if it would. In a new paper appearing in NPJ Genomic Medicine, a University of Melbourne-led team asked 409 non-genetics physicians about their engagement with genomic medicine, their genomics education, and their confidence to practice genomic medicine. They found that engaged participants were more likely to be pediatricians, to have recently completed a continuing education course in genomics, and to have genomics research experience. "Understanding the characteristics of those already engaged with genomics and those who feel confident to practice can inform learning needs and help educators provide genomics education that is fit for purpose," the researchers write in their paper. "Recognizing the relationships between engagement, confidence to practice genomic medicine, education, and preferred service models may also help define the role of education within broader implementation strategies."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.